Target Price | $3.50 |
Price | $1.11 |
Potential |
215.32%
register free of charge
|
Number of Estimates | 4 |
4 Analysts have issued a price target Cue Biopharma, Inc. 2025 .
The average Cue Biopharma, Inc. target price is $3.50.
This is
215.32%
register free of charge
$6.00
440.54%
register free of charge
$2.00
80.18%
register free of charge
|
|
A rating was issued by 4 analysts: 4 Analysts recommend Cue Biopharma, Inc. to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Cue Biopharma, Inc. stock has an average upside potential 2025 of
215.32%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 5.49 | 8.25 |
339.20% | 50.29% | |
Net Margin | -983.43% | -415.62% |
83.04% | 57.74% |
3 Analysts have issued a sales forecast Cue Biopharma, Inc. 2024 . The average Cue Biopharma, Inc. sales estimate is
This results in the following potential growth metrics:
2 Cue Biopharma, Inc. Analysts have issued a net profit forecast 2024. The average Cue Biopharma, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.11 | -0.71 |
25.50% | 36.04% | |
P/E | negative | |
EV/Sales | 5.83 |
2 Analysts have issued a Cue Biopharma, Inc. forecast for earnings per share. The average Cue Biopharma, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Cue Biopharma, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Cue Biopharma, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.